A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Recruiting now

Conditions studied: Knee Osteoarthritis

In brief

A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial

Key facts

Study ID

NCT07754175

Run by

Kang Stem Biotech Co., Ltd.

People needed

36

Starts

2026-07-20

Expected to finish

2032-02-28

Last updated by the study team

2026-08-10

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants who received placebo in the K0701 clinical trial and completed the Long-term follow-up study
• Participants who voluntarily provide written informed consent to participate in this extension study

You may not qualify if…

• Participants meeting any of the following criteria:
• Participants whom the investigator considers unsuitable for participation in this extension study.
• Pregnant or breastfeeding women, and women of childbearing potential or men who do not agree to use an appropriate method of contraception during the study

Where it is running

• CHA University Bundang Medical Center — Seoul, South Korea (enrolling)
• Kyung Hee University Hospital — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.